TheraNova is an experienced
medical device developer 

with a track record of creating innovative and practical solutions to large markets with unmet needs.

 
 

We create solutions and technologies with the potential to:

 

improve outcomes for patients

expand access to healthcare

reduce cost for patients or payers

 

TheraNova pursues a rapid, highly capital-efficient process incorporating all the needed elements of medical device development in a shared services model. 

Since its inception in 2005, TheraNova has been able to generate clinical data within a year of funding and with less than $1MM in financing.

 

improve patient outcomes

 

improve patient outcomes

expand access to healthcare

 

expand access to healthcare

reduce cost to patients and payers

 

reduce cost to patients and payers

 
 

Capabilites

TheraNova’s in-house engineering staff and network of specialists and suppliers have the expertise required for every step of the medical device development process

 

Engineering

Mechanical

Electrical

Manufacturing

Software

Electro-mechanical

Material Selection

Rapid Protoyping

3D Printing

Machining

Experimental Test Design

Silicone Molding

Management

Quality System Implementation

Clinical Study Execution

Coherence To FDA Guidelines

 

In addition to comprehensive engineering capabilities, 

TheraNova’s principals and staff have significant clinical, intellectual property, regulatory and quality system expertise. 

TheraNova and its spinouts have also worked closely with leading reimbursement consultants in the industry and have conducted clinical research in the United States, Europe, and South America.

 
 
 

Team

  • Description text goes here
 
  • Dr. Burnett received his M.D. from Duke University and concurrently obtained an M.B.A. from Duke’s Fuqua School of Business. Since 2006 Dr. Burnett has raised, or helped raise, over $250 MM for the fourteen TheraNova spinouts. He is an inventor on 57 issued patents and over 180 patents pending worldwide. He recently joined University of California San Francisco as an entrepreneur in residence with QB3 and as adjunct faculty in the Bioengineering Department.

 
 

Technologies

spinout technologies

TheraNova has created and spun-out a number of privately funded companies, including:

Next Generation Treatment for BPH
visit site

 

incubated technologies

Theranova’s portfolio of incubated companies is supported by a mix of internal capital, grant and angel funding.

For more information on our incubated programs or to learn about upcoming investment opportunities, please email us at info@theranova.com

 
 

Contact us

 

info@theranova.com
(555) 555-5555

123 Demo Street
New York, NY 12345

 

job opportunities

Theranova is continuously seeking to recruit the best bio-engineering talent to join our dynamic team. If you are interested in joining our team please drop us a line using our contact us link.